Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Tinzaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Gemcitabine 63 Fluorouracil 22 130-nm albumin-bound paclitaxel 19 Oxaliplatin 18 Leucovorin 13 Capecitabine 13 S 1 (combination) 12 Albumin-Bound Paclitaxel 12 Taxes 9 Radiosurgery 9 folfirinox 8 Irinotecan 8 Radiotherapy 6 Cisplatin 6 pembrolizumab 5 Pancreaticoduodenectomy 5 Drug Therapy 5 irinotecan sucrosofate 4 apatinib 4 Radiofrequency Ablation 4 Paclitaxel 4 Injections 4 Blood Specimen Collection 4 Biopsy 4 tislelizumab 3 rubitecan 3 Stents 3 Sorafenib 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05178628 2022-03-29

imPaCT-PRO

Institute of Molecular Medicine and Biomedical Research

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡